Page last updated: 2024-08-23

triciribine phosphate and Hematologic Neoplasms

triciribine phosphate has been researched along with Hematologic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burton, M; Faderl, S; Garcia-Manero, G; Kantarjian, HM; Lancet, JE; List, AF; Malik, A; Nowak, B; Plunkett, W; Ravandi, F; Sampath, D; Sebti, S; Verstovsek, S; Williams, B	1

Trials

1 trial(s) available for triciribine phosphate and Hematologic Neoplasms

Article	Year
Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies. Leukemia research, 2013, Volume: 37, Issue:11 Topics: Acenaphthenes; Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Phosphorylation; Prognosis; Proto-Oncogene Proteins c-akt; Ribonucleotides; Tissue Distribution; Tumor Cells, Cultured; Young Adult	2013

Article

Year

Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies.

Leukemia research, 2013, Volume: 37, Issue:11

Topics: Acenaphthenes; Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Phosphorylation; Prognosis; Proto-Oncogene Proteins c-akt; Ribonucleotides; Tissue Distribution; Tumor Cells, Cultured; Young Adult

2013